190 related articles for article (PubMed ID: 30430397)
21. Oridonin up-regulates expression of P21 and induces autophagy and apoptosis in human prostate cancer cells.
Li X; Li X; Wang J; Ye Z; Li JC
Int J Biol Sci; 2012; 8(6):901-12. PubMed ID: 22745580
[TBL] [Abstract][Full Text] [Related]
22. Oridonin induces G2/M cell cycle arrest and apoptosis in human oral squamous cell carcinoma.
Wang H; Zhu L; Feng X; Zhang H; Luo Q; Chen F
Eur J Pharmacol; 2017 Nov; 815():282-289. PubMed ID: 28935563
[TBL] [Abstract][Full Text] [Related]
23. The dual PI3K/mTOR inhibitor PKI-587 enhances sensitivity to cetuximab in EGFR-resistant human head and neck cancer models.
D'Amato V; Rosa R; D'Amato C; Formisano L; Marciano R; Nappi L; Raimondo L; Di Mauro C; Servetto A; Fusciello C; Veneziani BM; De Placido S; Bianco R
Br J Cancer; 2014 Jun; 110(12):2887-95. PubMed ID: 24823695
[TBL] [Abstract][Full Text] [Related]
24. Oridonin induces apoptosis and cell cycle arrest of gallbladder cancer cells via the mitochondrial pathway.
Bao R; Shu Y; Wu X; Weng H; Ding Q; Cao Y; Li M; Mu J; Wu W; Ding Q; Tan Z; Liu T; Jiang L; Hu Y; Gu J; Liu Y
BMC Cancer; 2014 Mar; 14():217. PubMed ID: 24655726
[TBL] [Abstract][Full Text] [Related]
25. Anticancer effects of oridonin on colon cancer are mediated via BMP7/p38 MAPK/p53 signaling.
Liu RX; Ma Y; Hu XL; Ren WY; Liao YP; Wang H; Zhu JH; Wu K; He BC; Sun WJ
Int J Oncol; 2018 Nov; 53(5):2091-2101. PubMed ID: 30132514
[TBL] [Abstract][Full Text] [Related]
26. Deprivation of asparagine triggers cytoprotective autophagy in laryngeal squamous cell carcinoma.
Ji Y; Li L; Tao Q; Zhang X; Luan J; Zhao S; Liu H; Ju D
Appl Microbiol Biotechnol; 2017 Jun; 101(12):4951-4961. PubMed ID: 28352997
[TBL] [Abstract][Full Text] [Related]
27. Oridonin-induced mitochondria-dependent apoptosis in esophageal cancer cells by inhibiting PI3K/AKT/mTOR and Ras/Raf pathways.
Jiang JH; Pi J; Jin H; Cai JY
J Cell Biochem; 2019 Mar; 120(3):3736-3746. PubMed ID: 30229997
[TBL] [Abstract][Full Text] [Related]
28. Synergistic antitumor activity of oridonin and arsenic trioxide on hepatocellular carcinoma cells.
Chen G; Wang K; Yang BY; Tang B; Chen JX; Hua ZC
Int J Oncol; 2012 Jan; 40(1):139-47. PubMed ID: 21947421
[TBL] [Abstract][Full Text] [Related]
29. Galangin suppresses human laryngeal carcinoma via modulation of caspase-3 and AKT signaling pathways.
Wang HX; Tang C
Oncol Rep; 2017 Aug; 38(2):703-714. PubMed ID: 28677816
[TBL] [Abstract][Full Text] [Related]
30. GE11 peptide conjugated selenium nanoparticles for EGFR targeted oridonin delivery to achieve enhanced anticancer efficacy by inhibiting EGFR-mediated PI3K/AKT and Ras/Raf/MEK/ERK pathways.
Pi J; Jiang J; Cai H; Yang F; Jin H; Yang P; Cai J; Chen ZW
Drug Deliv; 2017 Nov; 24(1):1549-1564. PubMed ID: 29019267
[TBL] [Abstract][Full Text] [Related]
31. Inhibition of nuclear factor κB transcription activity drives a synergistic effect of cisplatin and oridonin on HepG2 human hepatocellular carcinoma cells.
Dong X; Liu F; Li M
Anticancer Drugs; 2016 Apr; 27(4):286-99. PubMed ID: 26704389
[TBL] [Abstract][Full Text] [Related]
32. Glaucocalyxin A induces apoptosis and autophagy in tongue squamous cell carcinoma cells by regulating ROS.
Shi F; Xue D; Jiang Q; Qiu J
Cancer Chemother Pharmacol; 2021 Aug; 88(2):235-246. PubMed ID: 33904969
[TBL] [Abstract][Full Text] [Related]
33. Induction of G(2)/M phase arrest and apoptosis by oridonin in human laryngeal carcinoma cells.
Kang N; Zhang JH; Qiu F; Chen S; Tashiro S; Onodera S; Ikejima T
J Nat Prod; 2010 Jun; 73(6):1058-63. PubMed ID: 20496901
[TBL] [Abstract][Full Text] [Related]
34. Autophagy inhibits reactive oxygen species-mediated apoptosis via activating p38-nuclear factor-kappa B survival pathways in oridonin-treated murine fibrosarcoma L929 cells.
Cheng Y; Qiu F; Ye YC; Guo ZM; Tashiro S; Onodera S; Ikejima T
FEBS J; 2009 Mar; 276(5):1291-306. PubMed ID: 19187231
[TBL] [Abstract][Full Text] [Related]
35. HER3 Targeting Sensitizes HNSCC to Cetuximab by Reducing HER3 Activity and HER2/HER3 Dimerization: Evidence from Cell Line and Patient-Derived Xenograft Models.
Wang D; Qian G; Zhang H; Magliocca KR; Nannapaneni S; Amin AR; Rossi M; Patel M; El-Deiry M; Wadsworth JT; Chen Z; Khuri FR; Shin DM; Saba NF; Chen ZG
Clin Cancer Res; 2017 Feb; 23(3):677-686. PubMed ID: 27358485
[TBL] [Abstract][Full Text] [Related]
36. Autophagy counteracts apoptosis in human multiple myeloma cells exposed to oridonin in vitro via regulating intracellular ROS and SIRT1.
Zeng R; Chen Y; Zhao S; Cui GH
Acta Pharmacol Sin; 2012 Jan; 33(1):91-100. PubMed ID: 22158107
[TBL] [Abstract][Full Text] [Related]
37. Acetyl-macrocalin B suppresses tumor growth in esophageal squamous cell carcinoma and exhibits synergistic anti-cancer effects with the Chk1/2 inhibitor AZD7762.
Wang JN; Che Y; Yuan ZY; Lu ZL; Li Y; Zhang ZR; Li N; Li RD; Wan J; Sun HD; Sun N; Puno PT; He J
Toxicol Appl Pharmacol; 2019 Feb; 365():71-83. PubMed ID: 30633885
[TBL] [Abstract][Full Text] [Related]
38. Concurrent biological targeting therapy of squamous cell carcinoma of the esophagus with cetuximab and trastuzumab.
Yamazaki M; Yamashita Y; Kubo N; Yashiro M; Ohira M; Ako E; Tanaka H; Muguruma K; Sawada T; Hirakawa K
Oncol Rep; 2012 Jul; 28(1):49-54. PubMed ID: 22562413
[TBL] [Abstract][Full Text] [Related]
39. Oridonin inhibits the proliferation of human colon cancer cells by upregulating BMP7 to activate p38 MAPK.
Ren CM; Li Y; Chen QZ; Zeng YH; Shao Y; Wu QX; Yuan SX; Yang JQ; Yu Y; Wu K; He BC; Sun WJ
Oncol Rep; 2016 May; 35(5):2691-8. PubMed ID: 26986967
[TBL] [Abstract][Full Text] [Related]
40. Synergistic anticancer effects of combined γ-tocotrienol and oridonin treatment is associated with the induction of autophagy.
Tiwari RV; Parajuli P; Sylvester PW
Mol Cell Biochem; 2015 Oct; 408(1-2):123-37. PubMed ID: 26112904
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
